Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
HOUSTON, September 21, 2026--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors (the "Board") approved the appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.
The appointment of Nchacha Etta as Chief Financial Officer has put U.S. Physical Therapy (USPH) back on investor screens, as fresh leadership intersects with renewed debate over the stock’s discounted cash flow valuation. Recent trading has been constructive, with U.S. Physical Therapy showing a 29.87% 90 day share price return and a 5.92% 1 year total shareholder return, even though the 3 year and 5 year total shareholder returns are still in decline. Compare U.S. Physical Therapy’s renewed...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Earlier this year, U.S. Physical Therapy appointed Nchacha Etta as Chief Financial Officer, marking a change in leadership over the company’s finance function and capital management responsibilities. The move has drawn fresh attention to how effectively the business converts earnings into cash and how its long-term cash flows are being valued. We’ll now examine how the new CFO’s appointment and sharper focus on cash flow quality may influence U.S. Physical Therapy’s investment...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.